# Debate summary — idea 001

## Agreed

- The released LIDC-IDRI diagnosis records cannot presently be assumed to identify the specific XML nodule carrying the eight semantic ratings. Copying a patient-level diagnosis to every nodule would be label misattribution, not ordinary label noise (Round 1).
- Zinovev et al. (DOI 10.1007/s10278-011-9445-3) is the governing verified feasibility result: its conservative single-nodule rule yielded only 18 reliably linked nodules (8 malignant, 9 benign, 1 indeterminate), which is inadequate for the proposed eight-predictor nested-CV paired-AUC analysis at useful precision (Rounds 1–2).
- The endpoint should not be called “pathology-confirmed malignancy.” The defensible term is “confirmed clinical diagnosis,” with confirmation mechanism reported and tissue-confirmed cases treated as a sensitivity stratum (Round 1).
- Any linkage must be frozen without access to semantic attributes or malignancy ratings, and model fitting must be conditional on a prespecified precision criterion rather than on whether a classifier can technically be fit (Round 1).
- Applying one conservative linkage rule produces that rule's yield, not a true “linkage ceiling.” The nodule-count spreadsheet may distinguish single- from multi-nodule patients but does not itself identify the diagnosed XML nodule in ambiguous patients (Round 2).
- Unverified manual image matching is not a valid rescue under the current constraints because there is no demonstrated independent reference standard, diagnostic location evidence, or second adjudicator (Round 2).
- Reproducing the earlier linkage limitation would characterize dataset usability; it would not answer whether the semantic concepts predict disease. The linkage audit may serve as a private go/no-go check but is not a substitute publishable concept-validity study (Rounds 2–3).
- The card as written should be rejected rather than paused. The underlying medical question remains interesting and unresolved; what failed is the proposed LIDC-IDRI diagnosis file as an instrument for answering it (Rounds 3–5).
- Reopening requires a publicly released or independently validated mapping from confirmed diagnoses to specific XML nodules, retention of all eight semantic ratings, and independently verified benign and malignant counts that meet a prespecified confidence-interval-width target before model fitting (Rounds 3–5).
- The endpoint-practice audit remains only a logged spin-off. Promoting it would constitute a new idea, not a revision of this card (Rounds 1, 2, and 5).

## Unresolved

There is no remaining disagreement between proposer and critic about the disposition of this card.

The underlying empirical question remains unresolved: **Do the eight LIDC semantic attributes predict independently confirmed disease as well as they predict radiologist malignancy suspicion?** The proposer and critic agree that the present released linkage cannot answer it. Both would reconsider if a public or independently validated diagnosis-to-XML-nodule mapping retained all eight ratings and independently verified class counts satisfied a prespecified CI-width target before modeling. Such an artifact and precision calculation would settle feasibility; a valid paired analysis on that cohort would then address the scientific question.

Whether such a mapping already exists is also factually unresolved. Neither side verified one, and both recognize that failure to find one is not proof of absence. A primary-source and repository search yielding an auditable mapping—or establishing only that none was found under a documented search protocol—would update the evidence, although only a valid mapping would reopen this card.

## Positions that moved

- **Proposer, Round 1 — earned amendment.** In response to the critic's verified linkage evidence and sample-size objection, the proposer withdrew the original nested-CV paired-AUC experiment as immediately feasible, renamed and stratified the endpoint, introduced blinded linkage and a pre-modeling precision stop, and initially promoted linkage auditing to the main deliverable.
- **Critic, Round 2 — earned partial concession.** In response to those safeguards, the critic accepted that the Round 1 feasibility objection had been handled procedurally, then raised a new contribution-validity objection: the audit was neither a true ceiling nor an answer to concept validity.
- **Proposer, Round 2 — earned concession.** In response to that contribution-validity argument, the proposer withdrew the “linkage ceiling” claim, abandoned unverified manual matching, conceded that reproducing 18 cases lacks a publishable concept-validity inference, and demoted the audit to an internal gate.
- **Critic, Round 3 — earned acceptance.** The critic accepted those withdrawals as responsive to the mechanism of the objection and made explicit that no defensible study remained under the original card.
- **Proposer, Round 3 — earned concession.** In response to that explicit consequence, the proposer moved from leaving an internal gate attached to a paused idea to recommending outright rejection, while preserving the underlying question as unresolved.
- **Critic, Round 4 — earned concession.** In response to the proposer's adoption of rejection and a concrete reopening condition, the critic stated that no substantive objection remained and tightened the condition to require a pre-modeling precision demonstration using independently validated counts.
- **Proposer, Round 5 — earned concession.** The proposer adopted the critic's tighter reopening language and declared convergence.
- **Critic Round 6, proposer Round 7, critic Round 8, and proposer Round 9 — UNEARNED/redundant concessions.** No new argument or evidence was introduced after convergence in Round 5. These rounds restate the settled disposition and reopening test and should not be counted as additional consensus-building moves.

## Amendments made

At round zero, the idea claimed that a public LIDC pathology endpoint could be linked to the same nodules carrying eight semantic ratings, enabling a quick paired comparison between prediction of radiologist suspicion and prediction of disease. It described the endpoint as pathology-confirmed malignancy, proposed nested cross-validation and paired AUCs, treated a small gap as evidence licensing endpoint substitution, assigned a 4.45/5 priority score, and recommended `SHORTLIST`.

The final position withdraws that study. The endpoint is more accurately “confirmed clinical diagnosis,” but the released records have no verified, sufficiently large, auditable mapping to specific XML nodules. A recount under one rule is not a linkage ceiling, manual matching lacks adequate validation, and an imprecise null cannot validate endpoint substitution. The linkage check survives only as an internal reopening gate, not as the scientific deliverable.

What was lost is the original one-experiment concept-validity story, the claimed high value of either outcome, the strong novelty framing, and the expectation of an immediately feasible CPU-only study. The agreed card updates are `recommendation: REJECT`, priority score 2.85/5, reduced negative-result value and novelty confidence, and an explicit unverified-claims entry recording Zinovev et al.'s 18-nodule result as the governing prior evidence. The underlying medical question and the unpromoted endpoint-practice spin-off remain, but neither is an active revision of this idea.

## Recommendation

**REJECT** — as the single most important check before deciding, look for a publicly released or independently validated diagnosis-to-XML-nodule mapping that retains all eight semantic ratings, then verify *before model fitting* that its independently confirmed benign and malignant counts satisfy a prespecified CI-width target. Without that artifact, the proposed experiment cannot support its intended inference.
